Article ID Journal Published Year Pages File Type
4273363 The Journal of Sexual Medicine 2008 10 Pages PDF
Abstract
Intracavernous injection of low (0.4 µg) or intermediate‐concentration GDF‐5 (2 µg) was effective in preserving erectile function in a rat model of neurogenic erectile dysfunction. The underlying mechanism appears to involve neuron preservation and antiapoptosis. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin C‐S, Pohl J, and Lue TF. Intracavernous growth differentiation factor‐5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008;5:1866-1875.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Urology
Preview
Intracavernous Growth Differentiation Factor‐5 Therapy Enhances the Recovery of Erectile Function in a Rat Model of Cavernous Nerve Injury
Authors
, , , , , , ,